Successful concomitant therapy with mepolizumab and dupilumab for atypical eosinophilic granulomatosis with polyangiitis

被引：8
|
作者：
Anai, Moriyasu [1 ]
Yoshida, Chieko [1 ]
Ozono, Kazutaka [2 ]
Furukawa, Hirotsugu [1 ]
Ishimaru, Yuko [1 ]
Sakata, Shinya [1 ]
Saruwatari, Koichi [1 ]
Muramoto, Kei [1 ]
Tomita, Yusuke [1 ]
Saeki, Sho [1 ]
Ichiyasu, Hidenori [1 ]
Sakagami, Takuro [1 ]
机构：
[1] Kumamoto Univ, Dept Resp Med, Fac Life Sci, Kumamoto, Japan
[2] Kumamoto Univ, Dept Diagnost Pathol, Kumamoto, Japan
来源：
ALLERGOLOGY INTERNATIONAL | 2022年 / 71卷 / 02期
关键词：
D O I：
10.1016/j.alit.2021.11.003
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：259 / 261
页数：3
相关论文
共 50 条
  • [31] Efficacy of Increasing the Dose of Mepolizumab in Eosinophilic Granulomatosis with Polyangiitis
    Pallotti, Federica
    Bonniaud, Philippe
    Smets, Perrine
    Habib, Stephanie
    Perier, Amandine
    Deroux, Alban
    Mankikian, Julie
    Neel, Antoine
    Rousselin, Clementine
    Seror, Raphaele
    Taille, Camille
    Crickx, Etienne
    La Croix, Candice
    Blanche, Philippe
    Guillevin, Loic
    Puechal, Xavier
    Terrier, Benjamin
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3259 - 3261
  • [32] Low Dose of Mepolizumab in Treatment of Eosinophilic Granulomatosis with Polyangiitis
    Maia, A. P.
    San Martin, S. R.
    Erazo, A. C. E.
    Toledo, A. P.
    Oliveira, E. P.
    Assuncao, G. L.
    Barbas, C. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [33] Mepolizumab for the Treatment of Eosinophilic Granulomatosis With Polyangiitis: Our Experience
    Diaz-Campos, R. M.
    Prudencio-Ribera, V. C.
    Garcia-Moguel, I
    Fernandez-Rodriguez, C.
    Corral-Blanco, M.
    Jarrin-Estupinan, M. E.
    Melero-Moreno, C.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (05) : 384 - 385
  • [34] Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis
    Pradhan, Ravi Ranjan
    Nepal, Gaurav
    Mandal, Shobha
    PULMONARY MEDICINE, 2019, 2019
  • [35] Mepolizumab therapy in a pediatric patient with eosinophilic granulomatosis with polyangiitis associated with refractory myocarditis
    Ulu, Kadir
    Caglayan, Sengul
    Cetemen, Aysen
    Cakan, Mustafa
    Oner, Taliha
    Sozeri, Betul
    ARCHIVES OF RHEUMATOLOGY, 2023, 38 (02) : 326 - 328
  • [36] ATYPICAL CASE OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
    Hassan, Ahmad
    Chehade, Ahel El Haj
    Abdo, Tony
    CHEST, 2021, 160 (04) : 1739A - 1739A
  • [37] Eosinophilic Granulomatosis with Polyangiitis: Mepolizumab recommended in current Guideline
    Fessler, Beate
    ALLERGO JOURNAL, 2024, 33 (07) : 49 - 51
  • [38] MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS IN REAL WORLD DATA
    Shoda, T.
    Takeuchi, T.
    Nagai, K.
    Konma, J.
    Arawaka, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 689 - 689
  • [39] Dupilumab/Mepolizumab/PrednisoloneEosinophilic granulomatosis with polyangiitis, lack of efficacy and intolerance
    Reactions Weekly, 2024, 2008 (1) : 139 - 139
  • [40] Efficacy and Safety of Mepolizumab During Maintenance Therapy in Patients with Eosinophilic Granulomatosis with Polyangiitis
    Sakai, Daiki
    Kaneko, Kaichi
    Furukawa, Karin
    Kawazoe, Mai
    Matsuzawa, Yasuo
    Nanki, Toshihiro
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1345 - 1347
12345